Industry leaders explored the risks and benefits of adopting a China Plus One strategy at Advamed’s The MedTech Conference in ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating ...

Abbott Laboratories raised its 2024 earnings guidance after strong Q3 results, driven by growth in Pharma and MedTech ...

JNJ's 3Q earnings expected to be $2.21 EPS and $22.16B revenue. Recent acquisitions and drug trials impacting stock's ...

Authors:Kirk Harmon, Vice President & GM, Contract Sales Organization, IQVIAJavier “Jave” Castillo, R.Ph, Vice President, CSO ...

Here are eight key developments from spine and orthopedic devicemakers since Oct. 9. 1. Johnson & Johnson MedTech began the ...

Employees at the 10 largest medtech employers in the world are excited about culture but are still frustrated by corporate ...

Focus on international early-stage and pre-commercial biotech & medtech opportunities ...

Our 2024 Women in Medtech edition features insights from Abbott's Lisa Earnhardt, Medtronic's Nina Goodheart, and more.

Event puts focus on medical technologies Oct. 15-17 at the Metro Toronto Convention Centre ...